GlassScriptPhysician profile
Amir Qureshi
NPI 1609846435
$14,366.37
in general payments reported to CMS, 2019-2025
30 companies · $3,746 in 2025
The $3,746 reported for 2025 was more than what 88% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,437 · 2020: $487 · 2021: $3,415 · 2022: $2,159 · 2023: $1,272 · 2024: $850 · 2025: $3,746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,670 · Travel and Lodging: $2,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,669.99 |
| Travel and Lodging | $2,198.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,842.64 | 2019-2023 | Senza |
| Nalu Medical, INC. | $3,615.18 | 2021-2025 | Nalu Neurostimulation System |
| Spinefrontier, INC. | $1,919.92 | 2019-2025 | Sijfuse, Inspan, Facetfuse |
| Spinal Simplicity, LLC | $1,776.47 | 2021 | |
| Boston Scientific Corporation | $1,297.00 | 2020-2025 | Wavewriter Alpha Prime 16, Na, General - Therapies |
| Stryker Corporation | $531.13 | 2025 | Mild Device Kit, Optablate |
| Globus Medical, INC. | $258.69 | 2025 | Senza |
| Bone Support INC. | $165.48 | 2019 | |
| Foundation Fusion Solutions, LLC | $129.35 | 2024 | |
| Collegium Pharmaceutical, INC. | $118.02 | 2019-2023 | Xtampza |
| Sanofi-Aventis U.S. LLC | $88.45 | 2020-2023 | |
| Neuronetics, INC. | $72.22 | 2022 | |
| Captiva Spine INC | $65.73 | 2024 | Transfasten Lsf |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.46 | 2019-2023 | Relistor |
| Biodelivery Sciences International, INC. | $48.54 | 2020-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Camber Spine Technologies LLC | $47.91 | 2021 | |
| Medtronic, INC. | $43.80 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $35.27 | 2024-2025 | |
| Spr Therapeutics, INC | $34.30 | 2025 | Sprint Pns System |
| Abbott Laboratories | $33.62 | 2021 | |
| Biotronik INC. | $30.24 | 2022 | |
| Arbor Pharmaceuticals, INC. | $26.48 | 2021 | |
| Scilex Pharmaceuticals INC. | $20.75 | 2021 | |
| Si-Bone, INC. | $19.33 | 2024 | |
| Novo Nordisk INC | $17.48 | 2025 | Wegovy |
| Pacira Therapeutics, INC. | $17.00 | 2021 | |
| Allergan, INC. | $16.00 | 2021 | |
| Baudax Bio INC. | $13.87 | 2020 | |
| Pfizer INC. | $11.60 | 2019 | |
| Zyla Life Sciences, INC. | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Qureshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.